A strategic approach to COVID-19 vaccine R&D

doi:10.1126/science.abc5312

. 2020 May 29;368(6494):948-950.

doi: 10.1126/science.abc5312. Epub 2020 May 11.

A strategic approach to COVID-19 vaccine R&D

Lawrence Corey^{1

2}, John R Mascola³, Anthony S Fauci⁴, Francis S Collins⁵

Affiliations

¹ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
² Departments of Medicine and Lab Medicine, University of Washington, Seattle, WA 98195, USA.
³ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
⁴ National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. afauci@niaid.nih.gov.
⁵ National Institutes of Health, Bethesda, MD 20892, USA.

PMID: 32393526
DOI: 10.1126/science.abc5312

A strategic approach to COVID-19 vaccine R&D

Lawrence Corey et al. Science. 2020.

. 2020 May 29;368(6494):948-950.

doi: 10.1126/science.abc5312. Epub 2020 May 11.

Authors

Lawrence Corey^{1

2}, John R Mascola³, Anthony S Fauci⁴, Francis S Collins⁵

Affiliations

¹ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
² Departments of Medicine and Lab Medicine, University of Washington, Seattle, WA 98195, USA.
³ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
⁴ National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. afauci@niaid.nih.gov.
⁵ National Institutes of Health, Bethesda, MD 20892, USA.

PMID: 32393526
DOI: 10.1126/science.abc5312

No abstract available

PubMed Disclaimer

Comment in

Aggregating data from COVID-19 trials.
Ogburn EL, Bierer BE, Brookmeyer R, Choirat C, Dean NE, De Gruttola V, Ellenberg SS, Halloran ME, Hanley DF Jr, Lee JK, Wang R, Scharfstein DO. Ogburn EL, et al. Science. 2020 Jun 12;368(6496):1198-1199. doi: 10.1126/science.abc8993. Science. 2020. PMID: 32527823 Free PMC article. No abstract available.

Cited by

Immunotherapeutic advances in glioma management: The rise of vaccine-based approaches.
Andrew Awuah W, Shah MH, Tan JK, Ranganathan S, Sanker V, Darko K, Tenkorang PO, Adageba BB, Ahluwalia A, Shet V, Aderinto N, Kundu M, Abdul-Rahman T, Atallah O. Andrew Awuah W, et al. CNS Neurosci Ther. 2024 Sep;30(9):e70013. doi: 10.1111/cns.70013. CNS Neurosci Ther. 2024. PMID: 39215399 Free PMC article. Review.
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Fisher LH, Kee JJ, Liu A, Espinosa CM, Randhawa AK, Ludwig J, Magaret CA, Robinson ST, Gilbert PB, Hyrien O, Kublin JG, Rouphael N, Falsey AR, Sobieszczyk ME, El Sahly HM, Grinsztejn B, Gray GE, Kotloff KL, Gay CL, Leav B, Hirsch I, Struyf F, Dunkle LM, Neuzil KM, Corey L, Huang Y, Goepfert PA, Walsh SR, Baden LR, Janes H; COVID-19 Prevention Network (CoVPN). Fisher LH, et al. JAMA Netw Open. 2024 May 1;7(5):e2412835. doi: 10.1001/jamanetworkopen.2024.12835. JAMA Netw Open. 2024. PMID: 38780941 Free PMC article.
Spike 1 trimer, a nanoparticle vaccine against porcine epidemic diarrhea virus induces protective immunity challenge in piglets.
Li L, Yin S, Zhou J, Zhang L, Teng Z, Qiao L, Wang Y, Yu J, Zang H, Ding Y, Liu X, Sun S, Guo H. Li L, et al. Front Microbiol. 2024 Apr 8;15:1386136. doi: 10.3389/fmicb.2024.1386136. eCollection 2024. Front Microbiol. 2024. PMID: 38650887 Free PMC article.
Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis.
Villa S, de Colombani P, Dall'Olio L, Gargioni G, Raviglione M. Villa S, et al. BMJ Glob Health. 2024 Apr 22;9(4):e014630. doi: 10.1136/bmjgh-2023-014630. BMJ Glob Health. 2024. PMID: 38649181 Free PMC article.
Meningoradiculitis post-COVID-19 mRNA vaccination: A case report.
Landry A, Crapoulet S, Boudreau LH, Bourque C, Weston L, Pilote N, Desnoyers G, Chamard-Witkowski L. Landry A, et al. Clin Immunol Commun. 2022 Dec;2:76-78. doi: 10.1016/j.clicom.2022.03.004. Epub 2022 Mar 15. Clin Immunol Commun. 2022. PMID: 38620766 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A strategic approach to COVID-19 vaccine R&D

Affiliations

A strategic approach to COVID-19 vaccine R&D

Authors

Affiliations

Comment in

Similar articles

Cited by

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Comment in

Similar articles

Cited by

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources